Clinical note automation happens in one place, under one login
Across the healthcare landscape, the burden of documentation has long shadowed the act of healing — time spent writing notes is time not spent with patients. WriteUpp, a practice management platform serving tens of thousands of clinicians, has answered this tension by embedding an AI Medical Scribe directly into its existing system for Canadian practitioners, at CA$40 per user monthly. The significance lies not in the novelty of AI transcription, but in its placement: inside the compliance infrastructure Canadian clinicians already trust, removing the friction of adoption without adding new regulatory obligations.
- Canadian therapists and physiotherapists are losing significant clinical time to documentation, and the administrative weight is unsustainable for many private practices operating without the luxury of extra staff.
- Any AI tool touching patient data in Canada must navigate a layered web of federal and provincial privacy law — PIPEDA, PHIPA, and beyond — making third-party solutions a compliance risk many clinicians cannot afford to take.
- WriteUpp's scribe sidesteps that risk entirely by running on the same compliance infrastructure already governing its platform, meaning adoption requires no new vendor vetting and no separate regulatory burden.
- The tool supports real-time session recording, post-session dictation, and full template population for intake forms — covering the actual note formats clinicians use, not generic outputs they must reformat.
- With four free trial hours offered to all users and a modular licensing model, the platform lowers the barrier to entry while leaving the question of long-term value to be answered by clinicians in practice.
WriteUpp, a practice management platform used by more than 50,000 clinicians across the UK, Ireland, and Canada, has launched an embedded AI Medical Scribe for Canadian healthcare practices. Priced at CA$40 per user per month, the tool generates structured clinical notes directly inside the platform — no separate application, no additional login required.
The scribe supports the documentation formats practitioners actually rely on: SOAP, DAP, BIRP, and Brief Progress Notes. Clinicians can record live sessions and receive a structured first draft in real time, dictate notes after a session for free-text conversion, or have the AI populate entire intake and evaluation templates from a session recording — eliminating manual form completion.
What distinguishes the launch is less the technology than its regulatory grounding. Canadian clinicians operate under strict privacy frameworks at both federal and provincial levels. WriteUpp built the scribe on the same compliance infrastructure covering GDPR, PIPEDA, PHIPA, HIPAA, and ISO 27001 that already underpins its platform. A Canadian therapist adopting the tool inherits no new compliance obligation and need not vet an unfamiliar vendor.
The appetite for integrated solutions has been growing. Research cited by WriteUpp found that 61 percent of independent and physician-owned practices prefer a single platform for their entire operation, driven by cost savings and the desire to reduce administrative overhead. Private practices rarely have the capacity to add staff solely for documentation.
All existing and new users receive four free hours of the scribe as a one-time trial. After that, access requires a purchased license assigned to individual users — allowing practices to start with a single clinician and scale from there. The feature is off by default and must be activated by a site administrator.
WriteUpp's leadership framed the launch around a straightforward premise: Canadian clinicians want AI documentation that doesn't require them to leave the system they already trust. Whether the model gains lasting traction will depend on how well the AI performs under the pressure of real clinical workloads, and whether the time recovered justifies the ongoing cost.
WriteUpp, a practice management platform used by over 50,000 clinicians across the UK, Ireland, and Canada, has rolled out an embedded AI tool designed to handle one of the most time-consuming parts of clinical work: writing patient notes. The new feature, called AI Medical Scribe, costs CA$40 per user per month and generates structured clinical documentation directly inside the platform itself—no separate app, no extra login, no additional compliance headache.
The tool supports the note formats that therapists, physiotherapists, and mental health practitioners actually use: SOAP, DAP, BIRP, and Brief Progress Notes. It works in two main ways. During a live session, a clinician can record the patient encounter and have the AI generate a first draft of the structured note in real time, choosing from the available templates. After the session ends, there's a dictation mode where clinicians can speak their notes and the AI converts them to free text without requiring a template. For intake assessments and evaluation forms, the AI can populate the entire structured template directly from the session recording, saving the step of filling it out by hand afterward.
What makes this launch significant is not the technology itself—AI scribes exist—but where it lives and how it handles the regulatory reality of Canadian practice. Clinicians in Canada operate under strict privacy rules: PIPEDA at the federal level, PHIPA in Ontario, and various provincial requirements elsewhere. Any AI tool that touches patient data has to account for these standards. WriteUpp built the scribe to run on the same compliance infrastructure as the rest of its platform, which already covers GDPR, PIPEDA, PHIPA, HIPAA, and ISO 27001. That means a Canadian therapist adopting the tool doesn't inherit a separate compliance obligation or have to vet a new vendor's privacy practices.
The demand for this kind of solution has been building. Research cited by WriteUpp found that 51 percent of practices, and 61 percent of independent or physician-owned practices, prefer a single integrated platform for their entire operation. The reasons are straightforward: cost savings, integration efficiency, and reducing administrative burden. Private practices are stretched thin. Adding headcount to handle documentation isn't always feasible. An AI tool that sits inside the system clinicians already use, under the same login, with the same compliance coverage, removes friction from the adoption decision.
Every existing and new WriteUpp user gets four free hours of AI Medical Scribe as a one-time trial. After that, access pauses until a practice purchases a license and assigns it to individual users. Practices can start small—one license, one clinician—and expand as they see the time savings. The feature is disabled by default and has to be activated by a site administrator through the platform's integrations page.
Victoria Scott, WriteUpp's Head of Growth, framed the launch around a specific insight: Canadian clinicians already understand practice management software and what good workflow design looks like. What they want now is AI documentation that doesn't force them to leave the system they trust. Eric Lalonde, the company's CEO, echoed that logic: clinicians shouldn't have to choose between faster documentation and staying inside a single, compliant platform. The scribe is built on the premise that clinical note automation should happen in one place, under one login, with the same standards Canadian practices already rely on. Whether this pricing and integration model gains traction will depend on how well the AI actually performs in the hands of busy clinicians, and whether the time savings justify the monthly cost.
Notable Quotes
Canadian clinicians already understand practice management software and what strong workflow design looks like. What they want now is AI clinical documentation that lives inside their system.— Victoria Scott, Head of Growth at WriteUpp
Clinicians should not have to choose between faster documentation and staying inside the system they trust.— Eric Lalonde, CEO of WriteUpp
The Hearth Conversation Another angle on the story
Why does it matter that this tool lives inside WriteUpp rather than being a separate application?
Because clinicians are already stretched thin. If you're a therapist running a private practice, you're managing scheduling, billing, patient communication, and notes all in one place. Adding another app means another login, another vendor to trust with patient data, another compliance review. WriteUpp is saying: we'll handle the AI part inside the system you already use.
But AI scribes exist elsewhere. What's the actual advantage here?
Integration and compliance. Yes, there are standalone AI scribe tools. But they're separate subscriptions, separate logins, separate compliance obligations. A Canadian therapist using one of those has to make sure the vendor meets PIPEDA and PHIPA requirements. With WriteUpp's version, the compliance infrastructure is already there. It's one less thing to worry about.
The pricing is CA$40 per user per month. Is that competitive?
I don't have pricing data for other AI scribes to compare directly. But the model is flexible—you only pay for the users who actually need it, and you can start with one license and expand. That's designed to lower the barrier to adoption for small practices.
Why does the research about integrated platforms matter to this announcement?
It shows there's real demand. Sixty-one percent of physician-owned practices prefer a single integrated platform. That's not a niche preference. It's the majority. WriteUpp is betting that demand extends to AI documentation automation too—that clinicians want it built in, not bolted on.
What happens if a clinician uses up their four free trial hours and decides not to buy?
Access pauses. They can still use WriteUpp for everything else—scheduling, notes, billing—but the AI scribe stops working until they purchase a license. It's a soft paywall designed to let them experience the value before committing.
Does this solve the real problem—that clinicians spend too much time on documentation?
That's the bet. If the AI actually generates usable first drafts that clinicians can edit and finalize quickly, then yes. But the real test is whether clinicians actually use it and whether it saves them meaningful time. The announcement doesn't include usage data or testimonials from early adopters, so we don't know yet how well it performs in practice.